Molecular and biological characterization of a replication competent human immunodeficiency type 2 (HIV-2) proviral clone
about
Envelope glycoprotein cytoplasmic domains from diverse lentiviruses interact with the prenylated Rab acceptor.Evolutionary origin of human and simian immunodeficiency viruses.Human immunodeficiency virus type 2 produces a defect in CD3-gamma gene transcripts similar to that observed for human immunodeficiency virus type 1.The human immunodeficiency virus type 2 vpr gene is essential for productive infection of human macrophages.The nef gene of simian immunodeficiency virus SIVmac1A11Evolution of the primate lentiviruses: evidence from vpx and vprCD4-Pseudomonas exotoxin hybrid protein blocks the spread of human immunodeficiency virus infection in vitro and is active against cells expressing the envelope glycoproteins from diverse primate immunodeficiency retroviruses.Neutralizing monoclonal antibodies against human immunodeficiency virus type 2 gp120Inhibitory activity of the equine infectious anemia virus major 5' splice site in the absence of RevMapping the determinants of human immunodeficiency virus 2 for infectivity, replication efficiency, and cytopathicity.Variability of the env gene in cynomolgus macaques persistently infected with human immunodeficiency virus type 2 strain ben.Genetic diversity of human immunodeficiency virus type 2: evidence for distinct sequence subtypes with differences in virus biologyDistinguishing features of an infectious molecular clone of the highly divergent and noncytopathic human immunodeficiency virus type 2 UC1 strainStrain-specific neutralizing determinant in the transmembrane protein of simian immunodeficiency virus.Transdominant inhibition of wild-type human immunodeficiency virus type 2 replication by an envelope deletion mutant.Cross-neutralization of human immunodeficiency virus type 1 and 2 and simian immunodeficiency virus isolates.Role of the fusogenic peptide sequence in syncytium induction and infectivity of human immunodeficiency virus type 2.In vivo genetic variability of the human immunodeficiency virus type 2 V3 region.Dispensable role of the human immunodeficiency virus type 2 Vpx protein in viral replication.Persistent infection of rhesus macaques with a molecular clone of human immunodeficiency virus type 2: evidence of minimal genetic drift and low pathogenetic effects.Biological and molecular variability of human immunodeficiency virus type 2 isolates from The GambiaLocalization of immunogenic domains in the human immunodeficiency virus type 2 envelopeCytopathic variants of an attenuated isolate of human immunodeficiency virus type 2 exhibit increased affinity for CD4.Molecular characterization of an attenuated human immunodeficiency virus type 2 isolate.Identification of a cis-acting element in human immunodeficiency virus type 2 (HIV-2) that is responsive to the HIV-1 rev and human T-cell leukemia virus types I and II rex proteins.Human immunodeficiency virus types 1 and 2 and simian immunodeficiency virus env proteins possess a functionally conserved assembly domainA genotypic method for determining HIV-2 coreceptor usage enables epidemiological studies and clinical decision support.Hyperimmune antisera against synthetic peptides representing the glycoprotein of human immunodeficiency virus type 2 can mediate neutralization and antibody-dependent cytotoxic activity.Animal models for development of an AIDS vaccine.Location, exposure, and conservation of neutralizing and nonneutralizing epitopes on human immunodeficiency virus type 2 SU glycoprotein
P2860
Q24540298-69689B66-FC1A-47CA-8706-ADC16288EE65Q33604826-26E6E342-997F-4A89-8A66-5FB60433A6B8Q33814659-41F78C4F-1468-48C2-AE47-46D16B0FA8A2Q33849520-A76E1171-6A00-481A-9359-9665AE09541FQ33935811-0D82CD96-6235-4B35-8F9F-894A21527DCCQ33938392-F76DB24C-2FE8-4C4D-BC2C-867411AE57D0Q34323939-A856D2E0-F418-459D-862D-BD632AE64AB4Q35839457-329E1FF4-A2F9-4F5E-8EF9-127C188B298EQ35861329-57F99304-DC7B-4B84-A78C-83E760046E18Q36287468-6B141F2C-31A9-498A-8C80-FA215F2C677BQ36632917-5CD33392-4C4A-4C4E-A236-90FA52B9842AQ36637244-5F21182A-6AF0-4300-94AE-3FC20643CDC3Q36641861-AE9B4723-C54D-4E2F-9F35-21500029F656Q36684349-E372CAA8-0FD3-41E9-A394-175FFE2BDDF9Q36685908-E165A18E-4755-45E8-A970-4D0FB876CF47Q36698091-DF0795E3-5DCE-44AD-A9A6-3EA94A1F2D7AQ36699125-98651C52-C220-4E68-B16B-942719A02A12Q36699146-C7402821-77C0-454E-BE5D-DEE744542FDAQ36701891-530449D4-FE42-4817-B72C-B17CF5C5A43BQ36783146-1165672C-D723-4539-BC44-0CEC19D0032BQ36784415-5AEF4E05-BCE8-4885-8EEF-D45313AEBCBDQ36797905-F3DFDDD7-AA6D-4C2F-B3E8-52B28648D068Q36797933-766A9121-7BC2-4214-9837-8569946CBE69Q36801331-E268F814-3CEE-475F-A0AC-6E656D5FD939Q36803768-595DD317-50F0-4ED5-A8AD-FCB5A8EA5C2BQ36811248-11D1500F-8786-4938-B177-D83346A5298FQ37517645-1B095259-370A-4927-A025-D1815CD13308Q37546827-43C60795-54F0-4378-8692-431B47F0FEC9Q37844065-5057E77A-59AE-433F-B276-221EFF486D08Q39875204-6FA0B139-3833-447A-9583-EFA01BDD1819
P2860
Molecular and biological characterization of a replication competent human immunodeficiency type 2 (HIV-2) proviral clone
description
1989 nî lūn-bûn
@nan
1989 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1989 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
name
Molecular and biological chara ...... type 2 (HIV-2) proviral clone
@ast
Molecular and biological chara ...... type 2 (HIV-2) proviral clone
@en
type
label
Molecular and biological chara ...... type 2 (HIV-2) proviral clone
@ast
Molecular and biological chara ...... type 2 (HIV-2) proviral clone
@en
prefLabel
Molecular and biological chara ...... type 2 (HIV-2) proviral clone
@ast
Molecular and biological chara ...... type 2 (HIV-2) proviral clone
@en
P2093
P2860
P356
P1476
Molecular and biological chara ...... type 2 (HIV-2) proviral clone
@en
P2093
Biberfeld G
De Rossi A
Fargnoli KA
Franchini G
Giombini F
Jagodzinski L
P2860
P304
P356
10.1073/PNAS.86.7.2433
P407
P577
1989-04-01T00:00:00Z